HealthFDA approves US first mRNA flu vaccine for adults aged 50 and older
The US Food and Drug Administration approved the country’s first mRNA-based flu vaccine on Wednesday. Moderna, the drugmaker, said the vaccine is intended for adults aged 50 and older. The decision introduces an mRNA flu vaccine into the US market for the first time.
C
CNN★★★☆☆2026-08-06 05:01Original
FDA approves US first mRNA flu vaccine for adults aged 50 and older